We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Marijuana stocks have rallied in the past few weeks thanks mainly to rising possibility of a Biden victory in the presidential election. A Biden administration is expected to support decriminalization of recreational marijuana and legalization of medicinal marijuana at the federal level.
Medical use of marijuana is now legal in 33 states and in the District of Columbia, while its recreational use is legal in 11 states and DC. Some more states are expected to legalize marijuana’s recreational use soon.
Cannabis however remains illegal at the federal level. That results in major challenges for US marijuana companies.
A “Blue Sweep” could therefore be a game changer for the cannabis industry, which is growing rapidly. We could see a boom in domestic production. In fact, most Americans support marijuana legalization, but the industry is evolving rapidly and therefore these stocks are very volatile.
2019 was a terrible year for most pot stocks and the underperformance continued earlier this year. ETFs lower the risk of investing in this high-risk, high-reward industry.
The ETFMG Alternative Harvest ETF (MJ - Free Report) is the first and largest US listed ETF to target the global cannabis industry. Canopy Growth (CGC - Free Report) , Cronos (CRON - Free Report) and Aurora Cannabis (ACB - Free Report) are its top holdings. The Cannabis ETF (THCX) and the Global X Cannabis ETF (POTX) are also passively managed.
The AdvisorShares Pure Cannabis ETF (YOLO - Free Report) , the Cambria Cannabis ETF (TOKE - Free Report) and the Amplify Seymour Cannabis ETF (CNBS - Free Report) are actively managed. TOKE is the cheapest pot ETF. The newest product in the space-- AdvisorShares Pure US Cannabis ETF (MSOS - Free Report) --is an actively managed ETF that focuses exclusively on US cannabis stocks and swap contracts.
To learn more about these ETFs and their performance, please watch the short video above.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Why Cannabis Stocks & ETFs Are Soaring
Marijuana stocks have rallied in the past few weeks thanks mainly to rising possibility of a Biden victory in the presidential election. A Biden administration is expected to support decriminalization of recreational marijuana and legalization of medicinal marijuana at the federal level.
Medical use of marijuana is now legal in 33 states and in the District of Columbia, while its recreational use is legal in 11 states and DC. Some more states are expected to legalize marijuana’s recreational use soon.
Cannabis however remains illegal at the federal level. That results in major challenges for US marijuana companies.
A “Blue Sweep” could therefore be a game changer for the cannabis industry, which is growing rapidly. We could see a boom in domestic production. In fact, most Americans support marijuana legalization, but the industry is evolving rapidly and therefore these stocks are very volatile.
2019 was a terrible year for most pot stocks and the underperformance continued earlier this year. ETFs lower the risk of investing in this high-risk, high-reward industry.
The ETFMG Alternative Harvest ETF (MJ - Free Report) is the first and largest US listed ETF to target the global cannabis industry. Canopy Growth (CGC - Free Report) , Cronos (CRON - Free Report) and Aurora Cannabis (ACB - Free Report) are its top holdings. The Cannabis ETF (THCX) and the Global X Cannabis ETF (POTX) are also passively managed.
The AdvisorShares Pure Cannabis ETF (YOLO - Free Report) , the Cambria Cannabis ETF (TOKE - Free Report) and the Amplify Seymour Cannabis ETF (CNBS - Free Report) are actively managed. TOKE is the cheapest pot ETF. The newest product in the space-- AdvisorShares Pure US Cannabis ETF (MSOS - Free Report) --is an actively managed ETF that focuses exclusively on US cannabis stocks and swap contracts.
To learn more about these ETFs and their performance, please watch the short video above.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>